Mark A Lemmon, PhD, FRS

David A. Sackler Professor of Pharmacology; Co-director, Cancer Biology Institute

Departments & Organizations

Pharmacology: Primary Faculty

Yale Cancer Biology Institute

Yale Cancer Center: Signal Transduction | Yale CTAP

Yale Combined Program in the Biological and Biomedical Sciences (BBS): Biochemistry, Quantitative Biology, Biophysics and Structural Biology (BQBS) | Molecular Medicine, Pharmacology, and Physiology

Yale Cancer Biology Institute


Mark Lemmon, PhD was appointed the Co-Director of the Cancer Biology Institute and the David A. Sackler Professor of Pharmacology in 2015. Dr. Lemmon returns to Yale, where he completed his PhD in 1993, from the University of Pennsylvania’s Perelman School of Medicine. At UPenn, he was the George W. Raiziss Professor of Biochemistry and Biophysics as well as Chair of the department and an Investigator at the Abramson Family Cancer Research Institute. Dr. Lemmon’s research focuses on the signaling pathways of receptor tyrosine kinases (RTKs), which, when mutated cause cancers and other diseases.

Education & Training

PhD Yale University (1993)
BA Oxford University (Hertford College), Biochemistry (1988)

Edit this profile

Contact Info

Mark A Lemmon, PhD, FRS
Office Locations
Cancer Biology Institute OfficeWest Campus Advanced Biosciences Center
840 West Campus Drive, Fl 3 Rm 301

West Haven, CT 06516
View on map...
Medical School OfficeSterling Hall of Medicine, B-Wing
333 Cedar Street, Fl 3 Rm 326A

New Haven, CT 06510
View on map...
Mailing Address
PharmacologyDepartment of Pharmacology, Yale University School of Medicine
B326A Sterling Hall of Medicine

New Haven, CT 06520-8066

Lemmon and Ferguson Labs